News
-
Submit RDD Europe 2021 speaker and workshop proposals by August 1, 2020. For podium presentations, submit a 200-word summary at https://www.rddonline.com/rdd/speaker_reg.php?id=20 For company-sponsored workshops, submit proposals at https://www.rddonline.com/rdd/workshop_reg.php?id=20 At this time, program topics for the… Read more . . .
-
Nephron Pharmaceuticals said that it has hired Rita Boucher as Chief Quality Officer and is promoting Jamie Shuster to Chief Projects Officer and Stephanie Simmonds to Chief Clinical Officer. Boucher previously worked in quality assurance… Read more . . .
-
Altimmune has announced that a study of its AdCOVID intranasal vaccine candidate induced a strong immune response in a mouse model. The results support advancing AdCOVID into a Phase 1 development, the company said, and… Read more . . .
-
The United States Patent and Trademark Office has issued US Patent No. 10682414, titled, “Intranasal epinephrine formulations and methods for the treatment of disease,” to ARS Pharmaceuticals, the company said. The patent covers the use… Read more . . .
-
Teva has announced the US launch of the ProAir Digihaler albuterol DPI for the treatment of bronchospasm. The list price for the inhaler will be $146.67. ProAir Digihaler, which includes built-in sensors connected to a mobile app… Read more . . .
-
Inhalation solutions and suspensions manufacturer Nephron Pharmaceuticals has announced plans for a $215 million expansion at its South Carolina, USA facilities, including office, warehouse and vaccine production space. In addition to manufacturing its own products, Nephron also… Read more . . .
-
Optinose announced that it has signed an agreement with Kaleo for co-promotion of Optinose’s Xhance fluticasone propionate nasal spray for the treatment of nasal polyps. Xhance was approved by the FDA for that indication in… Read more . . .
-
Vienna-based biotech incubator CEBINA (Central European Biotech Incubator and Accelerator) said that in vitro testing has shown that azelastine has anti-SARS-CoV-2 activity, and the company is discussing possible development and production of an azelastine nasal spray for the… Read more . . .
-
Altimmune said that it has signed an agreement with DynPort Vaccine Company regarding Altimmune’s AdCovid intranasal vaccine candidate for COVID-19. The company announced in March 2020 that it had partnered with the University of Alabama Birmingham to… Read more . . .
-
Iconovo announced that BNC Korea has acquired rights to manufacture and market generic versions of Ultibro indacaterol/glycopyrronium and Seebri glycopyrronium DPIs based on Iconovo formulations and the company’s ICOcap device. The deal covers a territory… Read more . . .
Upcoming Events
Sponsored by Intertek
Want information about upcoming OINDP-related events delivered directly to your inbox? click here
July 13-July 16: 2026 ISAM Congress, Taipei, Taiwan
September 15-September 18: DDL New Researcher Network Summer Event, London, UK
September 16-September 17: IPAC-RS 2026 Nasal Innovation Forum, Jersey City, NJ, USA
September 24-September 25: Inhaled & Nasal Biologics | DNA Forum, Cambridge, UK
October 14-October 15: Advancing Bioequivalence Frameworks for Inhalation and Nasal Drug Products: Optimizing In Vitro, In Vivo, and In Silico Methods, Rockville, MD, USA